MS1 VALIDATION OF MODELED 5-YEAR SURVIVAL OUTCOMES AMONG PATIENTS WITH CYSTIC FIBROSIS (CF) TREATED WITH THE CF TRANSMEMBRANE CONDUCTANCE REGULATOR MODULATOR (CFTRM) IVACAFTOR USING US CF FOUNDATION PATIENT REGISTRY (USCFFPR) DATA
| Autor: | Mcgarry, L., Lopez, A., Chandler, C., Pelligra, C., Alkhateeb, Z., Rubin, J.L., Liou, T. |
|---|---|
| Zdroj: | In Value in Health May 2020 23 Supplement 1:S8-S8 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect